Gritta Janka

21.3k total citations · 6 hit papers
139 papers, 12.9k citations indexed

About

Gritta Janka is a scholar working on Hematology, Infectious Diseases and Immunology. According to data from OpenAlex, Gritta Janka has authored 139 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Hematology, 57 papers in Infectious Diseases and 56 papers in Immunology. Recurrent topics in Gritta Janka's work include Autoimmune and Inflammatory Disorders Research (78 papers), Parvovirus B19 Infection Studies (55 papers) and Immune Cell Function and Interaction (48 papers). Gritta Janka is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (78 papers), Parvovirus B19 Infection Studies (55 papers) and Immune Cell Function and Interaction (48 papers). Gritta Janka collaborates with scholars based in Germany, United States and Italy. Gritta Janka's co-authors include Jan‐Inge Henter, Maurizio Aricò, Shinsaku Imashuku, AnnaCarin Horne, Alexandra H. Filipovich, Stephan Ladisch, David Webb, Kai Lehmberg, Kenneth L. McClain and R. Maarten Egeler and has published in prestigious journals such as Blood, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Gritta Janka

138 papers receiving 12.6k citations

Hit Papers

HLH‐2004: Diagnostic and therapeutic gu... 1983 2026 1997 2011 2006 2019 1983 2011 2017 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
    2006 3.4k citations Jan‐Inge Henter, AnnaCarin Horne et al. Pediatric Blood & Cancer profile →
  2. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
    2019 598 citations Paul La Rosée, AnnaCarin Horne et al. Blood profile →
  3. Familial hemophagocytic lymphohistiocytosis
    1983 443 citations Gritta Janka profile →
  4. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
    2011 443 citations AnnaCarin Horne, Maurizio Aricò et al. Blood profile →
  5. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study
    2017 392 citations AnnaCarin Horne, Maurizio Aricò et al. Blood profile →
  6. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years
    2012 372 citations Itziar Astigarraga, R. Maarten Egeler et al. Pediatric Blood & Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gritta Janka Germany 50 10.7k 7.3k 6.8k 1.4k 1.4k 139 12.9k
Alexandra H. Filipovich United States 63 11.9k 1.1× 9.3k 1.3× 5.5k 0.8× 1.8k 1.3× 1.4k 1.0× 165 16.3k
Shinsaku Imashuku Japan 45 8.3k 0.8× 5.6k 0.8× 5.7k 0.8× 1.4k 1.0× 935 0.7× 315 12.0k
Kenneth L. McClain United States 55 6.7k 0.6× 5.4k 0.7× 6.8k 1.0× 2.9k 2.1× 737 0.5× 198 15.0k
David Webb United Kingdom 32 5.7k 0.5× 3.1k 0.4× 2.7k 0.4× 635 0.5× 677 0.5× 71 7.6k
Jacek Winiarski Sweden 39 5.0k 0.5× 3.2k 0.4× 2.4k 0.4× 712 0.5× 466 0.3× 147 8.1k
R. Maarten Egeler Netherlands 27 3.8k 0.4× 2.8k 0.4× 2.5k 0.4× 982 0.7× 467 0.3× 63 6.4k
AnnaCarin Horne Sweden 21 5.4k 0.5× 3.6k 0.5× 3.3k 0.5× 735 0.5× 731 0.5× 33 6.3k
Alexei A. Grom United States 48 5.0k 0.5× 3.6k 0.5× 1.8k 0.3× 1.4k 1.0× 1.4k 1.1× 122 7.4k
Göran Elinder Sweden 31 3.2k 0.3× 2.2k 0.3× 2.4k 0.3× 573 0.4× 390 0.3× 77 5.1k
Lionel Galicier France 47 3.5k 0.3× 3.8k 0.5× 2.0k 0.3× 663 0.5× 301 0.2× 184 7.8k

Countries citing papers authored by Gritta Janka

Since Specialization
Citations

This map shows the geographic impact of Gritta Janka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gritta Janka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gritta Janka more than expected).

Fields of papers citing papers by Gritta Janka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gritta Janka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gritta Janka. The network helps show where Gritta Janka may publish in the future.

Co-authorship network of co-authors of Gritta Janka

This figure shows the co-authorship network connecting the top 25 collaborators of Gritta Janka. A scholar is included among the top collaborators of Gritta Janka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gritta Janka. Gritta Janka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birndt, Sebastian, Thomas Schenk, Frank M. Brunkhorst, et al.. (2020). Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. Journal of Cancer Research and Clinical Oncology. 146(4). 1065–1077. 69 indexed citations
2.
Knaak, Cornelia, Peter Nyvlt, Friederike S. Schuster, et al.. (2020). Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore. Critical Care. 24(1). 244–244. 81 indexed citations
3.
Rosée, Paul La, AnnaCarin Horne, Melissa Hines, et al.. (2019). Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 133(23). 2465–2477. 598 indexed citations breakdown →
4.
Ehl, Stephan, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.. (2018). Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1508–1517. 118 indexed citations
5.
Machowicz, Rafał, Gritta Janka, & W Wiktor-Jędrzejczak. (2017). Similar but not the same: Differential diagnosis of HLH and sepsis. Critical Reviews in Oncology/Hematology. 114. 1–12. 111 indexed citations
6.
Janka, Gritta & Kai Lehmberg. (2014). Hemophagocytic syndromes — An update. Blood Reviews. 28(4). 135–142. 292 indexed citations
7.
Müller, Jürgen R., Birthe Jessen, Annette Schmitt‐Graeff, et al.. (2012). Hemophagocytic lymphohistiocytosis in syntaxin-11–deficient mice: T-cell exhaustion limits fatal disease. Blood. 121(4). 604–613. 58 indexed citations
8.
Pagel, Julia, Karin Beutel, Kai Lehmberg, et al.. (2012). Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 119(25). 6016–6024. 118 indexed citations
9.
Bode, Sebastian F. N., Kai Lehmberg, Andrea Maul‐Pavicic, et al.. (2012). Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Research & Therapy. 14(3). 213–213. 97 indexed citations
10.
Spix, Claudia, et al.. (2012). Parental informed consent in pediatric cancer trials: A population‐based survey in Germany. Pediatric Blood & Cancer. 60(3). 446–450. 4 indexed citations
11.
Yamamura, Jin, Regine Grosse, Andrea Jarisch, et al.. (2011). Pancreatic exocrine function and cardiac iron in patients with iron overload and with thalassemia. Pediatric Blood & Cancer. 57(4). 674–676. 11 indexed citations
12.
Kordes, Uwe, Andréa Richter, René Santer, et al.. (2010). Neonatal cholestasis and glucose‐6‐P‐dehydrogenase deficiency. Pediatric Blood & Cancer. 54(5). 758–760. 7 indexed citations
13.
Perez‐Becker, Ruy, Monika Szczepanowski, Ivo Leuschner, et al.. (2010). An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T‐cell acute lymphoblastic leukemia. Pediatric Blood & Cancer. 56(5). 859–862. 14 indexed citations
14.
Lehmberg, Kai, et al.. (2007). From Neonates to Adolescents - The Diagnostic Significance of Pitted Erythrocytes in Hyposplenic and Asplenic Children. Klinische Pädiatrie. 219(6). 339–342. 2 indexed citations
15.
Henter, Jan‐Inge, AnnaCarin Horne, Maurizio Aricò, et al.. (2006). HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer. 48(2). 124–131. 3420 indexed citations breakdown →
16.
Nielsen, Peter, et al.. (2002). SQUID-Biosuszeptometrie bei Eisenüberladungskrankheiten in der Hämatologie. Klinische Pädiatrie. 214(4). 218–222. 8 indexed citations
17.
Nielsen, Peter, et al.. (1995). Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. British Journal of Haematology. 91(4). 827–833. 59 indexed citations
18.
Haas, Robbert J. de, et al.. (1982). Verbesserte Prognose beim Wilms-Tumor durch adjuvante Kombinationschemotherapie. Oncology Research and Treatment. 5(2). 60–66. 1 indexed citations
19.
Haas, Rainer, et al.. (1982). Sogenannte Histiozytose-X und maligne Histiozytose. Oncology Research and Treatment. 5(1). 4–12. 1 indexed citations
20.
Janka, Gritta, et al.. (1977). [Neuroblastoma: paraneoplastic diseases and late complications (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 125(2). 69–73. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra H. Filipovich Breakdown of academic impact, for papers by Shinsaku Imashuku Breakdown of academic impact, for papers by Kenneth L. McClain Breakdown of academic impact, for papers by David Webb Breakdown of academic impact, for papers by Jacek Winiarski Breakdown of academic impact, for papers by R. Maarten Egeler Breakdown of academic impact, for papers by AnnaCarin Horne Breakdown of academic impact, for papers by Alexei A. Grom Breakdown of academic impact, for papers by Göran Elinder Breakdown of academic impact, for papers by Lionel Galicier
Rankless by CCL
2026